Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.
Vitamin A (retinol) is an essential cofactor for growth of B lymphocytes in culture and for activation of T lymphocytes by antigen receptor-mediated signals. 14-hydroxy-4,14-retro-retinol (14-HRR) a metabolite of retinol, has been implicated as the intracellular mediator of this effect. Anhydroretinol (AR) is a retinol derivative with retro structure produced in activated human B lymphocytes and the insect cell lines SF 21 and Schneider S2. AR reversibly inhibits retinol- and 14-HRR-dependent effects and blocks B lymphocyte proliferation as well as activation of resting T lymphocytes. The intracellular signaling pathway blocked by AR in T cell activation is distinct from the calcineurin/interleukin 2 pathway inhibitable by cyclosporine A or FK-506.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Journal of Biological Chemistry
12 publications, 15%
|
|
|
FASEB Journal
4 publications, 5%
|
|
|
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
3 publications, 3.75%
|
|
|
Tetrahedron Letters
2 publications, 2.5%
|
|
|
Journal of Investigative Dermatology
2 publications, 2.5%
|
|
|
Archives of Biochemistry and Biophysics
2 publications, 2.5%
|
|
|
Journal of Pharmacology and Experimental Therapeutics
2 publications, 2.5%
|
|
|
Nutrients
2 publications, 2.5%
|
|
|
Biochemistry
2 publications, 2.5%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 2.5%
|
|
|
Blood
2 publications, 2.5%
|
|
|
Current Opinion in Genetics and Development
1 publication, 1.25%
|
|
|
Current Opinion in Cell Biology
1 publication, 1.25%
|
|
|
Molecular and Cellular Endocrinology
1 publication, 1.25%
|
|
|
Cellular Immunology
1 publication, 1.25%
|
|
|
Experimental Cell Research
1 publication, 1.25%
|
|
|
Journal of Cell Science
1 publication, 1.25%
|
|
|
Toxicology and Applied Pharmacology
1 publication, 1.25%
|
|
|
Experimental Gerontology
1 publication, 1.25%
|
|
|
Molecules
1 publication, 1.25%
|
|
|
Nature Reviews Immunology
1 publication, 1.25%
|
|
|
Molecular Neurobiology
1 publication, 1.25%
|
|
|
Nature Reviews Drug Discovery
1 publication, 1.25%
|
|
|
Communications Biology
1 publication, 1.25%
|
|
|
Brain Research
1 publication, 1.25%
|
|
|
Pharmacology and Therapeutics
1 publication, 1.25%
|
|
|
Progress in Neurobiology
1 publication, 1.25%
|
|
|
Angewandte Chemie
1 publication, 1.25%
|
|
|
Immunology
1 publication, 1.25%
|
|
|
2
4
6
8
10
12
|
Publishers
|
5
10
15
20
25
|
|
|
Elsevier
23 publications, 28.75%
|
|
|
American Society for Biochemistry and Molecular Biology
12 publications, 15%
|
|
|
Springer Nature
7 publications, 8.75%
|
|
|
Wiley
5 publications, 6.25%
|
|
|
MDPI
4 publications, 5%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
4 publications, 5%
|
|
|
American Chemical Society (ACS)
4 publications, 5%
|
|
|
Taylor & Francis
3 publications, 3.75%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 2.5%
|
|
|
American Society of Hematology
2 publications, 2.5%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 1.25%
|
|
|
The Company of Biologists
1 publication, 1.25%
|
|
|
Oxford University Press
1 publication, 1.25%
|
|
|
Cambridge University Press
1 publication, 1.25%
|
|
|
Rockefeller University Press
1 publication, 1.25%
|
|
|
Annual Reviews
1 publication, 1.25%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.